We are excited to announce our partnership with Ra Pharma for RA101495-02.202: A Phase 2 Study of Zilucoplan in...
Featured news, clinical trials, MSU updates and more.
An Update on the Clinical Studies Using Arimoclomol as a Potential Treatment for Sporadic Inclusion Body Myositis VideoMyositis Support, , Featured, Inclusion Body Myositis (IBM)
The ongoing Arimoclomol Clinical Trial for sIBM continues to generate a lot of questions from our community. As part...
Identification of Predictors for Interstitial Lung Disease in Myositis Patients: A Systematic ReviewMyositis Support, , Featured, Myositis, News
Interstitial lung disease (ILD) is a well-recognized complication in the spectrum of diseases known as the idiopathic inflammatory myopathies...
September 21 @ 2:00 pm - 3:30 pm EDT
September 27 @ 5:00 pm - 6:30 pm EDT